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Abstract
Current materials used for in vitro 3D cell culture are often limited by their poor similarity to
human tissue, batch-to-batch variability and complexity of composition and manufacture. Here,
we present a “blank slate” culture environment based on a self-assembling peptide gel free
from matrix motifs. The gel can be customised by incorporating matrix components selected
to match the target tissue, with independent control of mechanical properties. Therefore
the matrix components are restricted to those specifically added, or those synthesised by
encapsulated cells. The flexible 3D culture platform provides full control over biochemical and
physical properties, allowing the impact of biochemical composition and tissue mechanics
to be separately evaluated in vitro. Here, we demonstrate that the peptide gels support the
growth of a range of cells including human induced pluripotent stem cells and human cancer
cell lines. Furthermore, we present proof-of-concept the peptide gels can be used to build
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disease-relevant models. Controlling the peptide gelator concentration allows peptide gel
stiffness to be matched to normal breast (<1 kPa) or breast tumour tissue (>1 kPa), with
higher stiffness favouring the viability of breast cancer cells over normal breast cells. In
parallel, the peptide gels may be modified with matrix components relevant to human breast,
such as collagen I and hyaluronan. The choice and concentration of these additions affect
the size, shape and organisation of breast epithelial cell structures formed in co-culture with
fibroblasts. This system therefore provides a means of unravelling the individual influences of
matrix, mechanical properties and cell-cell interactions in cancer and other diseases.
Keywords:
Biomaterials, Cancer, Stem cells, Extracellular matrix, Stiffness
1. Introduction
In many research areas, but particularly in cancer research and disease modelling, there
is an increasing emphasis on the use of biomaterials to grow cells in 3D [1, 2, 3]. It is
now well-understood that culturing most cells on 2D surfaces results in inferior physiological
conditions affecting cell morphology, phenotype and cell-matrix interactions [4, 5, 6]. As a
result, there is a growing body of literature focussed on the development of biomaterials as
biomimetic culture platforms, to produce more tissue-realistic cell behaviour in vitro. It has
become clear that there is unlikely to be a one-size-fits-all solution, with 3D in vitro culture
environments requiring the same capacity for variability and specificity as provided by natural
in vivo matrix microenvironments [1]. Therefore, the major hurdle still to be overcome is
the provision of a system that is both highly tunable and reproducible in composition and
mechanical properties.
Materials for 3D culture may broadly be separated into natural and artificially derived
materials [7]. Natural materials, most notably collagen gels and MatrigelTM, are the most
established, with a long history of use in tissue culture for applications ranging from cell
migration and invasion studies to regenerative medicine [8, 9, 10]. Since these materials are
commonly based on matrix proteins, cells grown on or within them are able to adhere and grow
to form tissue-realistic structures [9, 11]. However, the biological origin of natural materials
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also results in batch-to-batch variability and uncertainty in composition, most particularly for
MatrigelTM, a basement membrane extract derived from Engelbreth–Holm–Swarm mouse
sarcoma [12]. For this reason, and to provide opportunities for adding functionality, there has
been a shift in focus towards more highly defined, synthetic alternatives [7].
Apart from a few notable exceptions [13, 14], there have thus far been few models designed
specifically to allow customisable matrix composition. Similarly, many models have a matrix
component (commonly collagen, laminin or hyaluronan) as an essential part of their make-up,
making it hard to discriminate endogenous matrix production by encapsulated cells from the
3D matrix itself. Here, we present the optimisation of a self-assembling peptide gel as the
basis for a 3D culture platform with user-controlled composition, mechanical properties, and
cell-cell interactions. Based on a short, octapeptide gelator [15], the raw materials required for
the peptide gels can be produced reliably and rapidly and are widely commercially available.
By defining a protocol that enables independent control over mechanical and biochemical
properties, we aim to provide a platform technology suitable for studies decoupling the
influences of matrix stiffness and composition on cell behaviour. Here, we demonstrate the
application of the peptide gel to investigate the role of matrix stiffness and functionalisation
on a model of breast cancer.
2. Results
2.1. Controlled Gelation Produces a Fully-Defined Environment
Peptide gel fabrication is primarily a two-stage process, but with multiple degrees of
freedom engineered into the design as illustrated in figure 1(a). The first stage is to create
a matrix-free precursor by peptide dissolution in water. This precursor contains no organic
components other than the octapeptide gelator FEFEFKFK, the concentration of which will
determine the stiffness of the final peptide gel. The second stage is to incorporate the cells
and matrix components of interest for the desired application, yielding a final peptide gel with
user-defined stiffness, matrix composition and cellularity. The peptide itself is commercially
available from several suppliers, and importantly we have verified that our fabrication method
is effective for peptide preparations obtained from different companies.
This two-stage process is crucial as, to ensure homogeneity, the precursor must first be
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taken to the liquid state by modulation of pH and temperature. Since the precursor is cell-
and matrix-free, it can be heated to 80 C with no detrimental effects. Prior to cell and/or
matrix addition, the precursor is cooled to 37 C. Although the precursor is self-supporting at
37 C, its viscosity is sufficiently low to allow it to be treated as a liquid. In this way, cells and
matrix additions may be stirred into the gel by simple pipetting. Mixing the precursor gel with
these components at a 1:5 ratio produces a peptide gel with a final concentration of 6 mg/mL
FEFEFKFK peptide preparation. Sequential media washes then produce the final peptide
gel, which has higher viscosity than the precursor due to complete pH neutralisation.
Figure 1: Schematic illustrating the two-stage process of peptide gel fabrication, along with the
degrees of freedom achievable in design. (a) The initial formation of a cell- and matrix-free precursor
allows subsequent functionalisation by physically mixing in matrix components of interest. (b)
Quantification of the increase in complex viscosity between the precursor and the final 6 mg/mL
peptide gel, measured by microrheology and bulk oscillatory rheology. Trendlines of data collected
from 5 replicates are shown along with 95% confidence intervals (red).
To quantify this change in viscosity, we employed two measurement methods: bulk
oscillatory rheology, and microrheology measurements based on the Brownian motion of
micron-sized beads [16, 17]. As shown in figure 1(b), both measurement methods show
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approximately an order of magnitude increase in viscosity between the precursor and peptide
gel. Interestingly, the absolute values measured by microrheology are an order of magnitude
lower than those measured by bulk rheology. Since the viscosity measurements for control
samples (100% MatrigelTM for bulk rheology and pure water for microrheology, supplementary
figure 1) matched the expected literature values [18, 19], this difference appears to reflect
a property of the peptide gel itself. A similar difference between bulk and microrheological
properties was also observed for 100% MatrigelTM (supplementary figure 1(e)). It is therefore
likely that this is a more general property of some hydrogels. It has also recently been reported
that the normal force applied to a sample when setting up the bulk oscillatory rheometer can
impact the viscoelastic response of the material [20, 21]. It is possible that this, along with
the impact of material heterogeneity at each length scale [22], could have contributed to the
discrepancy between the bulk and microrheology measurements. Although exploring this
further was beyond the scope of the current study, we anticipate that microrheology will be
invaluable in future studies, investigating local variations in stiffness on the single cell scale.
However, since bulk rheology is an established method for materials characterisation, we
focussed on this technique for the remainder of the study.
In particular, we report an average value of the storage modulus G’ (at 1 rad/s) of
G’ = 600 ± 90 Pa for the 6 mg/mL peptide gel, and as a means of comparison, an average
value of G’ = 120 ± 20 Pa for 100% MatrigelTM (mean ± SEM) in agreement with previously
reported values [18]. These measurements therefore indicate that, whereas MatrigelTM is
acknowledged to provide a 3D culture environment with artificially low stiffness [23], peptide
gels may be produced with a final stiffness falling within the same range as many soft tissues
in vivo, with the 6 mg/mL condition particularly similar to the stiffness of normal breast [24].
2.2. Matrix-Free Environments Support Cell Viability
In its simplest form, peptide gel fabrication allows cells to be encapsulated in a matrix-free
environment, achieved by mixing the precursor with cells suspended in cell culture medium.
To demonstrate this, four cell lines were encapsulated in this way: mouse embryonic stem
cells (mES), human leukaemic cells (U937), human breast cancer cells (MCF7) and human
mammary fibroblasts (HMF). As shown in figure 2, although all cell types showed some
ability to grow within the matrix-free gel, the growth characteristics of the cell populations
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differed dramatically between lines. In particular, although the mES and U937 cells formed
large colonies within 7 days, as expected due to their anchorage independence, the adherent
MCF7 and HMF cell lines formed smaller colonies at a slower rate.
Figure 2: Bright field and fluorescence images of various cell lines growing in the 6 mg/mL peptide
gel, with initial seeding density of (a) 5x104, (b) 1x105, and (c) 5x105 cells/mL. All scale bars 50 µm.
To test the effect of seeding density on cell growth, each cell line was also suspended at
three seeding densities: 5x104, 1x105 and 5x105 cells/mL final gel. At the lowest seeding
density, mES and U937 both formed defined colonies with clearly distinguishable boundaries,
with mES cells forming a larger number of smaller colonies at high seeding density, and U937
rapidly colonising the entire gel with separate colonies merging together. MCF7 cells also
formed approximately spherical colonies at this seeding density, similar in morphology to the
mES cell colonies. HMF showed limited proliferation at all seeding densities, forming small
rounded clusters rather than the classic elongate morphology typical of fibroblasts [25].
The optical transparency of the peptide gels also allows quantitative read-outs of
fluorescence (reporters or constitutively expressed) and cell viability assays. Figure 3(a)
shows the increase in fluorescence signal relative to the value at day 0 for three cell lines: mES
with an Oct4-GFP reporter, mCherry-HCT116 colorectal cancer cells, and tdTomato-MCF7
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breast cancer cells. Each cell line gave a distinct growth profile. The fluorescence values for
both HCT116 and MCF7 increased steadily up to day 7, and whilst an approximately linear
increase in fluorescence over time was observed for MCF7, the increase for HCT116 became
even more pronounced towards day 7. The Oct4-GFP construct in the mES cells is active
in pluripotent cells and will switch off as the cells differentiate and Oct4 is down-regulated.
Monitoring for GFP over 7 days in 3D culture, we observed an increase in signal due to
proliferation (days 0-3), followed by a plateau (days 4-7). This in good agreement with the
images in figure 2(c), which show the formation of stable colonies by day 3. After this point,
the packed clusters of cells stop proliferating as rapidly and start differentiating, as seen by
the levelling off of GFP.
Quantitative fluorescent read-outs can be used in parallel with end-point fluorescent
immunostaining and microscopy, as shown in figure 3(b). In this case, peptide gels containing
E14 mES (without the Oct4-GFP reporter) and unlabelled MCF7 cell lines were fixed and
stained for the pluripotency marker Oct4 and the epithelial marker cytokeratin 18 (CK18)
respectively. Cells were seeded at 5x105 cells/mL so that, in each case, the gels could be
fixed at the time point where the cells gave their maximum fluorescent expression: day 3
for the mES cells, and day 7 for MCF7. This demonstrates that both real-time fluorescence
readouts and end-point staining of unlabelled cells can be used to examine cell growth and
behaviour within the peptide gels.
2.3. Embryoid Bodies Spontaneously Differentiate in Matrix-Free Peptide Gels
Increasingly, researchers and industry are recognising that the extracellular matrix (ECM)
plays a key role for in vitro control of stem cell pluripotency and differentiation, similar to its
essential role for in vivo development [26, 27, 28]. However, human induced pluripotent stem
cells (hiPSCs) are notoriously difficult to culture and differentiate reliably into mature functional
cell types, often requiring ill-defined complex matrices and/or the inclusion of small molecule
inhibitors of intracellular signalling. This is a problem in the field as potential therapeutic
applications and the need for robust reproducibility in disease models requires batch-to-batch
consistency and xeno-free/GMP-compliance of components used to support differentiation.
As shown in figure 4(a), hiPSCs encapsulated in the peptide gels as single cells formed
round, well-defined colonies by day 7 when cultured in E8 medium; a defined, xeno-free
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Figure 3: Methods for assaying cell growth and pluripotency in the 6 mg/mL peptide gels. (a)
Real-time measurements of % increase in signal relative to day 0, from fluorescently-tagged cell lines
encapsulated in matrix-free gels (seeding density 5x105 cells/mL). Graphs show mean ± standard
deviation for n=3 independent experiments. Trendlines are intended as a visual guide only. (b)
End-point immunostaining and microscopy of unmodified mES (Oct4 stain) and MCF7 (CK18 stain)
cell lines seeded within the matrix-free peptide gels. Scale bar 50 µm.
formulation. To drive rapid differentiation, hiPSCs were induced to form embryoid body (EB)
type clusters using the hanging-drop method. Following encapsulation of these clusters in
the peptide gel in E6 medium (xeno-free and lacking the FGF-2/TGF  required to maintain
hiPSC pluripotency) we observed good viability and dramatic changes in cell morphology
as expected for differentiating colonies, figure 4(b). To validate this, RNA was successfully
extracted from the hiPSC EBs encapsulated in peptide gels after 22 days of differentiation and
used to perform qRT-PCR for quantification of pluripotency and lineage-specific differentiation,
figure 4(c). Expression of NANOG and OCT4 (pluripotency) were markedly decreased
compared with control hiPSCs grown in E8 in 2D, and three germ layer markers TUBB3
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(ectoderm), GATA6 (endoderm) and HAND1 (mesoderm) all increased. This therefore
supports the application of the peptide gels as synthetic, fully-defined 3D environments to
support hiPSC differentiation with the potential to add functionality to direct differentiation and
enhance maturity in lineages of interest.
Figure 4: hiPSC growth and differentiation seeded in matrix-free 6 mg/mL peptide gels. (a) hiPSC
seeded as a single cell suspension at 1x106 cells/mL, (b) embryoid bodies (EBs) formed of 2000 cells
per EB, seeded at 8-10 EBs/gel and maintained in E6 medium. Scale bar 100 µm. (c) qPCR results for
EBs maintained to day 22 in E6. Fold expression is shown relative to hiPSC grown in 2D on vitronectin
to day 3, normalised to RPLPO. OCT4 and NANOG are used as markers of pluripotency, while TUBB3,
GATA6 and HAND1 are used as markers of ectoderm, endoderm and mesoderm respectively. Graphs
show mean ± SEM for n=2 independent experiments.
2.4. Control of Matrix Composition
The matrix-free environment of the peptide gels prevents attachment and spreading of
fibroblasts (as seen in figure 2), in contrast to their typical adherent culture morphology. To
examine this, HMF were encapsulated in 100% MatrigelTM, rat tail collagen I or the peptide gel.
Figure 5(a) shows that, after only 24 hours, the presence of matrix influences cell behaviour.
Relative to the cell free condition, a small degree of contraction is evident in the presence
of cells for the collagen gel, but not for the other materials. The fibroblasts display a typical
elongated morphology in the collagen gel by day 1, and by day 7 (figure 5(b)) this is also
evident in 100% MatrigelTM, but not in the peptide gel. As shown in figure 5(b), by day 7
the collagen gel has become a dense mass as contraction continues. MatrigelTM has also
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undergone a modest degree of contraction at day 7, with no contraction observed in the
matrix-free peptide gel. Phalloidin staining of F-actin revealed that the HMF formed a regular
network of elongated cells in collagen, dense clusters of elongated cells in MatrigelTM, and
sparse clusters of rounded cells in the peptide gel. This provides additional evidence for the
lack of cell-attachment motifs within the non-functionalised gel, making them effectively inert
to adhesive cell types.
Bulk oscillatory rheology was used to measure the mechanical properties of each material,
and to assess the impact of encapsulated cells (figure 4(c) and supplementary figure 2).
All measurements were taken at day 1 after seeding, since cell-matrix interactions were
observed at this time point in the absence of dramatic changes to the macroscopic material
properties. The presence of cells does not influence gel stiffness at day 1, however, the
peptide gel displays significantly higher stiffness (G’) than either MatrigelTM or collagen (figure
5(c)). The lack of interaction between cells and the peptide gel could therefore be influenced
by stiffness or matrix composition. To test this, fibroblasts were seeded into peptide gels
containing collagen I at 100 or 200 µg/mL. Although no significant change in stiffness or
viscoelasticity (supplementary figure 2) was observed relative to the unmodified peptide
gel, doubling collagen concentration resulted in a greater degree of cell elongation, as well
as modest gel contraction (figure 5(c) and (d)). This suggests that interaction between
HMFs and the peptide gel is determined primarily by matrix composition rather than stiffness.
To validate these results, we examined the distribution of phosphorylated focal adhesion
kinase (pFAK) within the encapsulated HMF. The increasing intensity of pFAK staining with
increased collagen concentration validates the observed differences in HMF morphology,
and demonstrates how simple functionalisation can alter behaviour of encapsulated cells by
controlling their cell-matrix interaction.
2.5. Distinguishing Exogenous and Endogenous Matrix
The ability to discriminate and visualise matrix functionalisation (exogenous) as opposed
to cell-deposited matrix (endogenous) is crucial for application of the peptide gels to the study
of cell-matrix interactions. Immunostaining and microscopy can be used to detect heparan
sulphate deposition by hiPSC (figure 6(a)) and collagen I deposition by MCF7 (figure 6(b),
upper panel) seeded in matrix-free peptide gels, highlighting predominantly cell-associated
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Figure 5: Human mammary fibroblast (HMF) elongation and contraction in peptide gels is influenced
by matrix modifications. (a) Macroscopic contraction and HMF morphology at day 1 in 100%MatrigelTM,
1.5 mg/mL rat tail collagen I gel and unmodified 6 mg/mL peptide gel, all seeded at 5x105 cells/mL;
(b) contraction and HMF morphology with Phalloidin staining at day 7; (c) box plots (n=5) of bulk
oscillatory rheology measurements of each condition at day 1, with and without encapsulated HMF
(individual MatrigelTM and collagen data points not included for clarity), along with results from peptide
gels with increasing collagen I modification; (d) contraction and HMF morphology at day 7 in peptide
gels with increasing collagen I modification. (e) pFAK staining of modified and unmodified peptide
gels at day 7. Bright field images have been sharpened (using Fiji software) to facilitate comparison of
fibroblast morphology. All macroscopic images are 3 mm across, and contraction is shown relative to
the cell free condition at day 1: original images can be found in supplementary figure 2. Scale bar
100 µm (bright field images), 50 µm (Phalloidin images), 25 µm (pFAK images). * indicates p<0.05
(two-way ANOVA with Tukey post-hoc).
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but non-uniform distribution in the 3D cultures.
When we applied the same technique to visualise collagen I in a modified peptide gel,
again confocal microscopy revealed a positive collagen I signal, although this showed some
spatial heterogeneity as displayed in the single z-slice in figure 6(b), upper right panel. It was
not possible to distinguish using this technique whether this heterogeneity was a true reflection
of the collagen I localisation within the gel, or a limitation of the in situ (whole gel) staining
and imaging method. To clarify this, gels were embedded in agar blocks to allow sectioning.
As a first test, the agar blocks were paraffin-embedded to allow microtomy and haematoxylin
and eosin (H&E) staining (lower panel, figure 6(b)). This method was successful in revealing
the cross-sectional structure of cell clusters, while preserving gel integrity. To facilitate
immunostaining of collagen I throughout the gel, the agar blocks were thick-sectioned at 500
µm using a vibratome, rather than paraffin-embedding. This alternative approach meant that
the resulting hydrated sections could be immunostained directly, avoiding the rehydration
and antigen retrieval stages necessary following paraffin-embedding (see supplementary
figure 3). As shown in figure 6(c), this method was successful for immunostaining both
endogenous and exogenous collagen I. Multiple matrix components could be visualised
clearly in vibratome-generated sections (figure 6(d)), where the same MCF7 structures grown
in peptide gel with collagen I additions showed endogenously deposited hyaluronic acid (HA).
We observed a clear distinction between the relatively homogeneous distribution of collagen I
(exogenous matrix) and the cell-localised deposition of HA (endogenous matrix). Increased
intensity of collagen I staining was observed around cell clusters, likely to be the result of both
endogenous collagen I production (see figure 6(c)) and localised interactions of the cells with
the exogenous collagen. Again, the peptide gel model provides the opportunity to access
and probe these events, assaying changes in matrix composition and organisation driven by
reciprocal interaction with encapsulated cells.
2.6. Independent Control of Matrix Stiffness
A benefit of the peptide gels is that their mechanical properties may be altered with no
change in matrix composition, simply by controlling the amount of peptide preparation added
to the precursor. We used this approach to create peptide gels with G’ values spanning an
order of magnitude, from 500 Pa to 5 kPa (figure 7(a)). Importantly, this range is relevant to
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Figure 6: Exogeneous and endogenous matrix may be distinguished using immunostaining in 6
mg/mL peptide gels. (a) Heparan sulphate (HS) deposition by human induced pluripotent stem cells
(1x106 cells/mL), (b) collagen I localisation on culture with MCF7 in unmodified peptide gel or with
collagen I modification, with corresponding H&E (5x105 cells/mL), (c) improved collagen I localisation
on embedding and sectioning (seeding density reduced to 1x105 cells/mL for 100 µg/mL collagen to
avoid overconfluence at day 7 in this condition), (d) co-stain for exogenous collagen I and endogenous
HA (biotinylated hyaluronic acid binding protein, bHABP, detected using TRITC-streptavidin) in peptide
gel modified with collagen I (1x105 cells/mL). Negative control images can be found in supplementary
figure 4. Scale bar 100 µm for fluorescence images in panel (b), otherwise all scale bars are 50 µm.
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human tissue: increasing the peptide gel concentration from 6 to 15 mg/mL yields a change in
G’ representative of the increasing tissue stiffness associated with tumourigenesis in breast
cancer, figure 7(b) [29]. This raised the interesting question of how human breast cell lines
representative of different stages of malignancy would respond to culture under this range
of stiffness conditions. Figure 7(c) shows the results of a cell viability stain following 7 days
culture of three cell lines in each peptide gel concentration: MCF10A (non-tumourigenic,
normal breast), MCF10DCIS.com (ductal carcinoma in situ, pre-invasive) and MCF7 (invasive
breast cancer). Interestingly, the more malignant the cell type, the greater its viability in
the peptide gels, with only MCF7 forming stable clusters across all conditions. Limited
DCIS.com acinar growth was also seen in the lowest peptide gel stiffness. Otherwise, no
acini were observed, and very few viable MCF10A or DCIS.com were detected in the highest
stiffness 15 mg/mL gels. Matched quantification of gel stiffness and cell viability within a
representative experiment (supplementary figure 5) confirmed that changes in stiffness with
peptide concentration were constant between the cell lines, and therefore that the changes
in viability are cell-type specific responses to their mechanical environment. In addition to
the effect of matrix stiffness, it is also of note that the viscoelastic response of the gels, as
quantified by the loss modulus G” and the G”/G’ ratio tan   (figure 7(d, e)), also changes with
peptide concentration. In particular, tan   shows a significant decrease in magnitude with
increasing peptide concentration. This indicates a decreasing relative contribution from the
viscous (energy loss) material response: a factor recently identified as crucial for determining
the extent of matrix remodelling [30]. Even in the absence of relevant matrix proteins and
glycosaminoglycans, the peptide gels may therefore be used to probe the effect of mechanical
environment on cell behaviour and relative survival, as demonstrated using cell models of
breast cancer progression.
2.7. Enhancing Cell Viability using Multicellular Models
Another degree of freedom in peptide gel design is the ability to add more than one cell
type in co-culture. This may be achieved by encapsulating multiple cell types within the same
gel (figure 8(a)) or alternatively by culturing the peptide gel in a transwell insert, with a second
cell type at the base of the well (figure 8(b)). This approach allows cell-cell interactions
to be studied when the cells are in direct or indirect co-culture, as illustrated in figure 8(c).
Co-culturing MCF10A breast epithelial cells with HMFs allows the MCF10A to form clusters
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Figure 7: Increasing peptide gel concentration produces corresponding increase in stiffness. (a)
Box plots (n=6) showing G’ results of increasing peptide gel concentrations characterised using bulk
oscillatory rheology, (b) schematic of the increase in malignancy in breast cancer associated with
increasing matrix stiffness, (c) LIVE/DEAD staining of breast epithelial cell lines MCF10A, DCIS.com
and MCF7 in peptide gels of increasing stiffness. Box plots (n=6) showing (d) G” and (e) tan  
measurements correspond to the G’ values shown in (a). Scale bar 100 µm. * indicates p<0.05
(one-way ANOVA with Tukey post-hoc).
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in both 6 mg/mL and 10 mg/mL peptide gels, either in (a) direct or (b) indirect co-culture -
in contrast to their lack of viability in stiffer gels in monoculture (see figure 8(d)). A CK18
(epithelial cell specific) co-stain with Phalloidin was used to distinguish between MCF10A
and HMF clusters, revealing that, in the direct co-culture conditions, HMF formed small,
distinct clusters in all peptide gel concentrations (supplementary movie 1). Interestingly, the
ability of HMFs to support MCF10A viability does not require direct contact, with MCF10A
acini observed in indirect co-culture in the 10 mg/mL gels and single cells/small clusters in
15 mg/mL gels. The lack of Phalloidin+/CK18- cells verifies that no HMFs were able to
penetrate the transwell filter and migrate into the gel during indirect co-culture. Comparing
the impact of indirect co-culture with HMFs between MCF10A, DCIS.com and MCF7s, the
normal breast cell line demonstrated the most marked difference in growth with stromal
cell conditioning of the gel enabling the MCF10As to form tight cell clusters. Co-culture
in non-functionalised gels had less impact on the morphology or growth of encapsulated
DCIS.com or MCF7s (figure 8(d)).
2.8. Matrix Additions Support MCF10A 3D culture
Building on our initial observation that adding ECM components to the peptide gel
altered stromal cell growth and viability (figure 5), we investigated the effect of varying
matrix composition on MCF10A cell behaviour. Rheological characterisation of 10 mg/mL
peptide gels (figure 9(a) and supplementary figure 6) showed that whereas additions of 100
µg/mL collagen I or 20% MatrigelTM produced stiffnesses closer to that of normal breast
tissue (G’ = 800 ± 200 and 1400 ±500 Pa respectively, mean ± SEM), the addition of
804 kDa HA significantly increased peptide gel stiffness in either the presence or absence
of collagen I (G’ = 3200 ± 400 and 3000 ± 700 Pa respectively). Interestingly, peptide
gels with HA modifications alone showed behaviour closer to an elastic solid than the other
modified conditions, as characterised by a significant decrease in tan   (supplementary figure
6(b)). Immunostaining (or use of an HA binding peptide) enables visualisation of the matrix
components added to the gel, demonstrating that both components are homogeneously
distributed throughout the gel (figure 9(b)).
In contrast to the lack of growth observed in the unmodified peptide gel, MCF10A 3D
growth and the formation of cell clusters was supported in all modified conditions (figure
16
Figure 8: Co-culture with HMF supports MCF10A viability. (a) Direct co-culture of both MCF10A and
HMF within the gel, white arrows indicate CK18- clusters, i.e. HMF, (b) MCF10A within the gel with
HMF indirect co-culture, (c) schematic illustrating the set-up of each co-culture variant, (d) indirect
co-culture of the three breast epithelial cell lines MCF10A, DCIS.com and MCF7 (6 mg/mL peptide
gels). Each cell type was seeded at 5x105 cells/mL, shown at day 7. Scale bar 50 µm for CK18 stain
in panel (d), otherwise all scale bars are 100 µm.
9(c)). However, only the 20% MatrigelTM condition was able to promote formation of the
classic polarised single-cell layer acini typically observed in 100% MatrigelTM (supplementary
figure 7), with peripheral collagen IV deposition (indicative of a nascent basement membrane)
by day 14 (figure 9(d)). This highlights that additional or alternative influences, beyond
functionalisation with collagen I and HA, are required for this complex cell behaviour, in
agreement with previously published studies [31, 32].
We next investigated how independent control of matrix stiffness, composition and
co-culture conditioning could alter MCF10A organisation. Functionalisation with collagen I
significantly decreased the stiffness of a 10 mg/mL peptide gel (figure 10(a) and supplementary
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Figure 9: MCF10A growth and morphology is dictated by matrix additions. (a) Box plots (n=6) showing
bulk oscillatory rheology of 10 mg/mL peptide gels with matrix modifications, (b) immunostaining of
collagen I and HA distribution in the modified 10 mg/mL peptide gels seeded with MCF10A (DAPI,
blue, scale bar 50 µm), (c) acinar morphology in modified 10 mg/mL gels at day 14 (scale bar 100
µm), (d) single cell acinus formed in 20% MatrigelTM at day 14 (scale bar 50 µm (left), 25 µm (right)). *
indicates p<0.05 (one-way ANOVA).
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Figure 10: Combined control of matrix additions and co-culture influences MCF10A organisation. (a)
Box plots (n=6) showing bulk oscillatory rheology results of peptide gels with and without matrix
modifications, * indicates p<0.05 relative to all other conditions (one-way ANOVA), (b) acinar
morphology on indirect co-culture with HMF, (c) acinar morphology in MCF10A monoculture in
10 mg/mL peptide gels with matrix additions, (d) acinar morphology on indirect co-culture with HMF in
10 mg/mL peptide gels with matrix additions, (e) quantification of acinar diameter for each condition,
* indicates p<0.05 relative to all other conditions (Kruskal-Wallis, >25 acini across 2 independent
experiments per condition), (f) immunostaining of an acinus surrounded by collagen I matrix in a 10
mg/mL peptide gel modified with 200 µg/mL collagen I. Scale bar 50 µm.
figure 6). Therefore, a 6 mg/mL peptide gel with equal stiffness to the collagen-containing
conditions was included as a matrix-free control. After 14 days of culture, immunostaining
revealed that neither the presence of collagen I (figure 10(b)) nor indirect co-culture with
HMFs (figure 10(c)) was sufficient to produce organised acinar structures, indicated here by
the lack of focused cleaved caspase 3 staining in the core of MCF10A clusters. However,
where applied in combination, collagen I and HMF co-culture produced large acini, with
evidence in the 100 µg/mL collagen I condition of organised cleaved caspase 3 staining, an
early stage of lumen formation (figure 10(d)). Quantification of acinar diameter (figure 10(e))
revealed that HMF co-culture produced a significant increase in acinar size in peptide gels
containing 100 µg/mL collagen I. A significant increase in diameter was also observed on
increasing collagen concentration from 100 to 200 µg/mL, although the acini formed in the
200 µg/mL condition were dense with no central lumen, as shown in figure 10(b).
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Interestingly, although it is clear that additional or alternative matrix functionalisation
is required to promote further acini maturation, the MCF10As were able to organise and
re-engineer their surrounding matrix, indicating reciprocal interactions between the
encapsulated cells and their local environment. After 14 days MCF10A culture in a peptide
gel containing 200 µg/mL collagen I, figure 10(f), the epithelial cells appear to distort the
collagen, with collagen excluded entirely from the cell cluster and surrounding the acinus at
its periphery.
3. Discussion
An increasing awareness of the importance of matrix components in regulating cell
behaviour has necessitated the continued improvement of in vitro 3D models of human tissue.
As recently highlighted in a high-profile technology feature, the ECM governs a surprising
number of cellular functions, which must be adequately modelled in vitro to better understand
development, differentiation and the progression to disease [1]. A major hurdle to this has
been unpicking the multitude of influences exerted by the matrix on neighbouring cells. The
self-assembled peptide gel presented here allows the independent control of two critical
factors: matrix composition and bulk stiffness. This in turn facilitates the application of
customised (“bespoke”) gels to mimic multiple matrix microenvironments tailored for specific
applications.
Self-assembling peptide gels are intermediates between natural and synthetic materials;
chemically synthesised, but formed from natural building blocks, with a biomimetic, fibrillar
nanostructure [23, 33]. Here, the octapeptide gelator sequence FEFEFKFK was chosen
due to the high biocompatibility demonstrated by gelation at pH 7 at 37 C [15]. Previous
studies have explored the application of similar gels for regenerative medicine applications
[15, 34] however, to our knowledge they have not yet been used to create fully-defined
matrices for cell encapsulation. By exploiting the pH-dependent viscosity of the gels, we
could physically incorporate cells and/or matrix components into the precursor, and these
remained homogeneously distributed on final gelation.
Previously, decoupling of matrix stiffness and composition to detect their respective
influence on cell behaviour has often been conducted in the presence of a complex matrix
environment. For instance, ribose-mediated collagen cross-linking was used to increase the
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stiffness of a collagen-rBM (reconstituted basement membrane) composite, demonstrating
that ErbB2 signalling was necessary to promote mammary epithelial invasion in stiff matrices
[9]. In an alternative approach, rBM was combined with alginate gels to determine the interplay
between matrix stiffness and rBM concentration, with greater epithelial cell malignancy
observed in stiffer matrices only when rBM concentration was held constant [18]. A similarly
elegant approach combined collagen with methacrylated gelatin, allowing independent control
of collagen concentration and matrix stiffness [35]. Using this system, the authors discovered
that MDA MB 231 breast cancer cell invasion was best supported by matrices with low
stiffness but high collagen concentration. By using a non matrix-derived self-assembling
peptide gel as a starting point, the method described here is distinct from these approaches in
that it not only allows independent control of matrix and mechanical properties, but also allows
the inclusion of selected matrix components, specific for the application. This flexibility is
permitted by the two-stage fabrication method; the first stage creates a matrix-free precursor
to define the stiffness, the second stage defines the composition.
We were able to demonstrate the increase in viscosity during gelation of the matrix-free gel
using two distinct measurement techniques: bulk oscillatory rheology, and microrheological
measurements based on the Brownian motion of micron sized beads embedded in the gel.
Indeed, despite the absolute measurement values obtained from the two methods differing
by approximately an order of magnitude (likely due to the different length scales explored by
the two techniques), the relative increase in viscosity on gelation was found to be very similar
between the two experimental procedures. Nonetheless, bulk rheology is a well-established
experimental method, allowing us to compare the viscoelastic properties of the peptide gel
with those of other established 3D cell culture platforms. Whereas naturally derived gels,
such as MatrigelTM/rBM and collagen tend to be far less stiff than the tissues they are used to
mimic [23], we are able to control the peptide gel storage modulus in the range 500 - 5000 Pa,
which covers a wide range of in vivo tissue stiffnesses, such as brain and breast [23, 29, 36].
It is important to note, however, that bulk rheology is not well-suited to measuring cell-induced
changes in gel mechanical properties during culture. This is because it cannot measure
local material changes at the length scale of a single cell. Therefore, we are developing a
novel microrheology method, combined with the ability to optically trap a bead in the case
of low modulus gels [37, 38, 39], to measure the gels’ mechanical properties at a cell-scale;
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particularly at the cell-matrix interface, as cells re-engineer their microenvironment.
In good agreement with our current understanding of cell-matrix interactions, anchorage-
independent cells proliferate within unmodified peptide gels, with the lack of matrix attachment
motifs effectively enabling the cells to form structures similar to those seen in suspension
culture. Adhesive cell types, such as fibroblasts, additionally require matrix components,
such as collagen I, to achieve their characteristic morphology. Importantly, the gel formulation
method presented here allows for biochemical functionalisation, whilst also providing control
conditions with matched peptide gel stiffness. Although cell adhesion motifs have classically
been considered necessary for interactions between matrix stiffness and cell behaviour [40],
we have also shown a clear link between stiffness and cell response in the absence of
cell binding sequences. It has recently been demonstrated that cells encapsulated in 3D
materials rapidly synthesise their own matrix, with initial matrix stiffness implicated as a key
factor determining the extent of this early matrix deposition [30, 41]. Importantly, the peptide
gels allow independent assessment of the effects of biochemical functionalisation and of the
mechanical environment initially presented to encapsulated cells.
In trying to create artificial culture environments where the control of biochemical and
physical properties is required, researchers often combine naturally derived and synthetic
elements. This can be seen in the chemical modification of natural materials, e.g. hyaluronic
acid with thiol modifications to allow cross-linking, or in the incorporation of biological
components into synthetically produced hydrogels [23] as well as the current study. A
particularly successful approach is that taken by the Lutolf group, functionalising synthetic
polyethylene glycol (PEG) hydrogels with laminin-111 to produce highly complex tissue
models, including the human intestine [13]. Matrix remodelling by encapsulated cells can
be regulated and reported by the inclusion of matrix metalloproteinase (MMP) cleavable
cross-links or reporters [23]. Within the peptide gels, encapsulated cells appear to readily
organise and remodel their surrounding matrix without the need to engineer in specific
cleavage sites. The ability to image both endogenous and exogenous matrix within the
fully-synthetic system is a significant advantage here and will enable monitoring of matrix
reorganisation as cells grow, differentiate and migrate. Another feature of importance to cell
biologists is the optical transparency of the peptide gel that enables simple assessment of
cell growth in real-time by microscopy. The ability to use automated plate readers to read-out
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endogenous fluorescence as well as end-point analysis by immunostaining and fluorescent
microscopy is likely to be useful for high-throughput analyses and applications such as toxicity
screening or biomarker identification.
The ability to investigate the impact of stromal cells in co-culture with epithelial cells
is particularly valuable when studying the microenvironmental control of cancer initiation,
growth and metastasis. Bidirectional cross-talk is thought to promote cancer progression,
with exosomal-mediated signalling between neighbouring cells likely to play an important
role [42, 43, 44]. Stromal cells can additionally alter the hormone-dependence of nearby
epithelia: for instance estrogen treatment of uterine epithelial cells increased their proliferation
only when in culture with stromal cells [45]. For some effects, direct cell contact appears to
be unnecessary, with the exposure of epithelial cancer cells to stromal-conditioned media
sufficient to alter their sensitivity to chemotherapy and radiation [46]. In the current study,
we were able to demonstrate differences in the behaviour of encapsulated cells when in the
presence of direct or indirect stromal cell co-culture, with the flexibility of the culture system
providing an useful test environment in which to study the regulation of cancer cells by their
microenvironment.
As demonstrated in multiple studies, a benefit of using short peptides to create hydrogels
for cell encapsulation is the ability to simply and cheaply engineer-in covalently immobilised
peptidic functional motifs e.g. matrix-derived cell adhesion sequences (RGD, IKVAV etc.) A
less reductionist approach can also be achieved by functionalisation with complex sequences,
combining cell attachment and proteolytic motifs [47]. These approaches have clear benefits
for mechanistic investigations and additionally highlight the potential for using peptide gels to
move to fully synthetic xeno-free, matrix-inspired 3D culture. In the current study, we chose
to incorporate full-length proteins and glycans to enable the visualisation of cell-mediated
changes in matrix organisation, detailing cell contraction and immunocytochemical imaging of
matrix organisation and synthesis. Importantly, by using “naked” matrix free gels, we can also
detail matrix deposition by encapsulated cells. This is particularly valuable when studying
glycans such as heparan sulphate where the conservation of structure between species
makes it impossible to differentiate glycosaminoglycans deposited by encapsulated (human)
cells from those present in complex animal-derived matrices (e.g. MatrigelTM). Cell-deposited
matrices have themselves been used for 3D culture [5] and the study of differential ECM
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deposition under different conditions, such as stromal activation in the presence of cancer
cells [48] is increasingly studied to identify potential targets for novel therapeutic strategies.
The use of indirect stromal cell co-culture to effectively condition the peptide gels will hopefully
prove useful in these studies.
4. Conclusions
In summary, we present the optimisation of a well-established, simple and relatively
inexpensive peptide gel for the study of cell-matrix interactions in a wide variety of cell
types. By eliminating or significantly reducing the need for animal-derived components e.g.
MatrigelTM, this synthetic gel also helps researchers move away from the batch-to-batch
variability associated with their use, and addresses the need to replace, refine and reduce the
use of animals in research. The cell encapsulation protocol has been specifically designed
to ensure that reliable, reproducible 3D culture is achievable within a standard cell culture
laboratory setting with independent control of the biochemical and mechanical influences
of the matrix microenvironment. In this study, as well as demonstrating broad applicability
across multiple adhesive and non-adhesive cell types, we have demonstrated how the peptide
gel can be applied to unpick the role of extracellular regulation on the behaviour of cell lines
used to model the progression from normal breast to breast cancer. We hope the peptide
gels will be of interest to the matrix biology community, with the optimised protocol and
commercially available precursors ensuring that the technology is approachable for any cell
culture laboratory.
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6. Experimental Procedures
6.1. Cell Line Maintenance
The human mammary fibroblast cell line HMFU19 (a gift from Professor Mike O’Hare,
Ludwig Institute, London, UK), leukemia cell line U937 (DSMZ GmBH) and colorectal cancer
line mCherry-HCT116 (a gift from Prof. Anna Grabowska, University of Nottingham) were
cultured in HMF cell culture medium: RPMI-1640 with 10% fetal bovine serum (FBS) and
1% L-glutamine. The murine embryonic stem cell line E14TG2a and Oct4-GFP reporter line
(both gifts from Prof. Austin Smith, University of Cambridge, UK) were maintained on tissue
culture flasks coated with 0.1% gelatin (G1890 Sigma), in knockout Dulbecco’s modified Eagle
medium (DMEM) with 10% FBS (HyClone), 1% Non Essential Amino Acids, 1% L-glutamine,
0.1%   mercaptoethanol, and leukemia inhibitory factor (LIF, ESG1107 Millipore). The breast
cancer cell line MCF7 and the modified tdTomato-MCF7 (a gift from Prof. Anna Grabowska,
University of Nottingham) were maintained in high glucose DMEM with 10% FBS and 1%
L-glutamine. The breast cell line MCF10DCIS.com (Asterand) was cultured in advanced
DMEM with 5% horse serum and 1% L-Glutamine. MCF10A were maintained in DMEM/F12
(D8062 Sigma) with 5% horse serum, 1% L-Glutamine, 10 µg/mL insulin (I9278 Sigma), 0.5
mg/mL hydrocortisone (50237 Tocris), 20 ng/mL epidermal growth factor (ABC016 Source
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Biosciences) and 100 ng/mL cholera toxin (C8052 Sigma). All cell lines were obtained from
ATCC unless specified.
6.2. hiPSC Culture and EB formation
For human induced pluripotent stem cell experiments (hiPSC), REBL-PAT (non-disease)
cells were used as established and characterised previously [49]. hiPSC were maintained in
Essential 8 medium (E8) on tissue culture flasks coated with recombinant vitronectin peptide
(VTN-N) following manufacturer’s instructions. For hiPSC passage, cells incubated with
TrypLE Express were collected in E8 supplemented with 10 µM Y-27632 ROCK inhibitor
(72304, Stem Cell Technologies, UK). The hanging drop method used to generate embryoid
bodies (EBs) from hiPSCs was adapted from [50]. hiPSCs were harvested 48 hours after
seeding and resuspended in E8 with 10 µM Y-27632 and 4 mg/mL polyvinyl alcohol (Sigma,
UK). 20 µL droplets containing 2000 cells/droplet were pipetted onto the lid of a 10 cm petri
dish containing 10 ml PBS to maintain hydration. The EBs were formed for 24 hours at 37 C,
then collected in DMEM. EBs were allowed to sediment at the bottom of a 15 ml falcon tube
for 10-15 minutes at 37 C and were subsequently cultured in peptide gels maintained in
Essential 6 medium (E6) to allow spontaneous differentiation.
All cell lines were maintained in antibiotic-free conditions, at 37 C and 5% CO2 in a
humidified atmosphere. All media components were obtained from Gibco, UK unless
specified.
6.3. Precursor Formation
A commercially available peptide preparation in powder form was used as the source
of the octapeptide gelator (FEFEFKFK, Phe-Glu-Phe-Glu-Phe-Lys-Phe-Lys). As part of
this study we used peptide sourced from Cambridge Research Biochemicals (batch 32597)
although we also verified the fabrication method using a second peptide source (Pepceuticals,
UK). To form each precursor, a mass of between 7.5 and 18.75 mg peptide preparation was
dissolved in 800 µL sterile water (W3500 Sigma), using a 3 minute vortex step followed by
centrifugation (3 minutes at 1000 rpm) and a 2 hour incubation at 80 C. After incubation, 0.5
M NaOH (S2770 Sigma) was added incrementally to the gels until optically clear. Gels were
vortexed, buffered by addition of 100 µL 10X PBS (70011 Gibco), and incubated at 80 C
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overnight. The resulting precursors could be stored at 4 C until required.
6.4. Peptide Gel Formation
Prior to peptide gel formation, each precursor was heated at 80 C until liquid to ensure
homogeneity, before transferring to a 37 C water bath. Peptide gel formation was then
induced by pH neutralisation on addition of cell culture medium. A final volume of 1.25 mL
was obtained from each preparation, by adding 250 µL of cell culture medium to a precursor
volume of 1 mL. The end concentration of peptide preparation therefore ranged between 6
and 15 mg/mL. Medium was thoroughly mixed with the precursor by gentle (reverse) pipetting,
before plating at 100 µL per well into a 96-well plate, or at 200 µL per well into a hanging
insert within a 24-well plate (MCRP24H48 Millipore). The wells were then flooded with cell
culture medium and incubated at 37 C and 5% CO2 in a humidified atmosphere. Sequential
media changes (at least two) over the next 24 hours ensured complete neutralisation and
therefore gelation.
For cell encapsulation, the 250 µL volume of cell culture medium was prepared as a cell
suspension at 5x the intended final seeding density, to allow for the dilution factor on mixing
with the precursor. Trypsin-EDTA (0.25%), or TrypLE Express in the case of REBL-PAT,
was used to detach all adherent cell lines from 2D culture at sub-confluence. Cells were
resuspended in 250 µL cell culture medium at a density between 2.5x105 and 5x106 cells/mL,
giving final seeding densities in the peptide gel between 5x104 and 1x106 cells/mL.
6.5. Peptide Gel Formation with Matrix Modifications
Modified peptide gels were created using the method above, by incorporating matrix
additions into the 250 µL volume added to the precursor. For collagen I additions, rat tail
collagen I (A10483 Gibco) was neutralised directly before use with 1 M NaOH according to
manufacturer instructions, and diluted with sterile water and 10X PBS to a concentration of
0.5-1.5 mg/mL. For hyaluronic acid (HA) additions, streptococcal HA polymer with molecular
weight 804 kDa (HA804 Iduron) was reconstituted in PBS at 0.5 mg/mL and sterilised using
a 0.2 µm syringe filter. Corning MatrigelTM (354234 Fisher Scientific) was used for the 20%
MatrigelTM condition. All matrix preparations were kept on ice. Modified peptide gels were
created by preparing a 250 µL volume containing each matrix component at 5x the desired
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final concentration (diluted with cell culture medium if necessary), and mixing with 1 mL
precursor as described above. Cells were incorporated into this 250 µL volume at 5x the
desired final seeding density as described.
6.6. MatrigelTM and Collagen Gels
Neutralised rat tail collagen I was prepared at 1.5 mg/mL as described above, and plated
at 200 µL per well into a 24-well plate hanging insert. Corning MatrigelTM was plated in the
same way. All solutions were kept on ice during use. To seed cells into these gels, a cell pellet
was prepared and suspended in either the neutralised collagen solution or in pure MatrigelTM,
giving a final seeding density of 5x105 cells/mL. MatrigelTM and collagen gels were incubated
at 37 C and 5% CO2 in a humidified atmosphere for 30 minutes to allow gelation, before
flooding the wells with cell culture medium.
6.7. Bulk Oscillatory Rheology
Peptide gel samples were prepared for bulk rheology as described above, by plating at
200 µL per well into 24-well plate hanging inserts, and incubating overnight as described
above. At day 1 after seeding, samples were removed from the inserts with a scalpel and
mounted onto a Physica MCR 301 rheometer (Anton Paar) with Peltier plate set to 37 C.
The linear viscoelastic region was determined for each sample condition by carrying out an
amplitude sweep from 0.1 to 100% strain at 1 rad/s. Following this, a constant strain of 0.5%
was used to obtain frequency sweeps from 0.1 to 100 rad/s, as well as 5 minute time sweeps
at a constant frequency of 1 rad/s. The same tests were carried out on the precursor samples,
which could be pipetted directly onto the rheometer plate. All tests were carried out using an
8 mm diameter parallel plate set-up with a spacing of 1 mm.
6.8. Microrheology
The microrheological properties of both precursor and peptide gel were tested by measuring
the Brownian motion of 2 µm diameter polystyrene beads (19814 Polysciences) embedded
into the samples. For the precursor, beads were suspended at a final concentration of
2x105 beads/mL by incorporating them with the addition of 10X PBS. This relatively low
bead concentration was chosen to avoid clustering and to ensure that only one bead was
present in the field of view for the duration of the experiment. After a standard overnight
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incubation at 80 C, precursor samples were equilibrated for one hour at 37 C and 5% CO2 in
a humidified atmosphere prior to transfer into an 8-well coverslip (80821 IBIDI) at 200 µL/well
for testing. For the peptide gel, beads were added to the gel by suspension into the 250 µL
of cell culture medium used for neutralisation, at a final concentration of 2x105 beads/mL.
Peptide gels were seeded into the 8-well coverslips and incubated at 37 C and 5% CO2 in a
humidified atmosphere overnight. The beads were imaged in wide-field transmission with a
100x oil-immersion objective lens (numerical aperture = 1.3) using an inverted microscope
(Eclipse Ti-S, Nikon) and a CMOS camera (Optimos, QImaging). The trajectories of 5
individual beads per condition were tracked using a centre of mass algorithm. For each bead
at least 50000 frames were recorded at a frame rate of 600 frames per second (exposure
time 1500 µs), this high frame rate was achieved by imaging a small region of interest. For
some measurements, the number of frames was limited by the bead diffusing out of the
field of view (for such gels the adoption of a relatively low laser power for optically trapping
the bead of interest could be considered in future studies). In-house LabVIEW programs
(LabVIEW, 2013, National Instruments, USA) were used for (i) bead tracking, (ii) trajectory
conversion to mean squared displacement, and (iii) for extracting the complex viscosity of
the gel immediately surrounding the beads [51]. The experimental set-up was verified by
taking control measurements of the viscosity of water (supplementary figure 1). For these
experiments, a 1064 nm continuous wave laser (Ventus 1064, Laser Quantum Ltd, UK)
operating at spatial Gaussian mode (TEM00) was used to optically trap beads suspended in
water with a laser power < 5 mW. 500000 frames were recorded at a frame rate of 600 fps.
6.9. Live Cell Imaging and Detection
Fluorescence signal from peptide gels containing fluorescently labelled cells was detected
using a Fluostar Omega Plate Reader (BMG LabTech). An Eclipse TI-S microscope (Nikon)
was used for bright field imaging during culture. For quantification of cell cluster diameter, all
regions containing cell clusters were imaged and Fiji software was used for manual diameter
measurement [52]. For LIVE/DEAD staining, peptide gels were washed with PBS, removed
from their hanging inserts, and incubated for 15 minutes in a solution of 40 µM Ethidium
homodimer and 20 µM calcein AM (L3224 Fisher) in PBS. A Leica TCS SPE laser scanning
confocal microscope was used for acquisition of fluorescence images.
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6.10. Immunofluorescence Staining
After washing in PBS, and removal from hanging inserts if necessary, peptide gels were
incubated for one hour in paraformaldehyde (Polysciences) diluted to 4% (v/v) in PBS.
Samples were washed in PBS in preparation for immunofluorescence staining. Samples were
incubated in blocking buffer, consisting of 0.1% Triton X-100 and 0.5% bovine serum albumin
(Sigma) for 1 hour, and incubated overnight at 4 C with a solution of primary antibody in
blocking buffer: Oct4 (83932 Cell Signalling Technologies (CST), 1:400), CK18 (53981582
Thermofisher, 1:50-1:100), rabbit IgG (PP64, Chemicon International, 1:1000), pFAK (Tyr397,
44-624G Thermofisher, 1:100) collagen I (ab34710 AbCam, 1:100-1:500), collagen IV
(ab6311 AbCam, 1:200), cleaved caspase 3 (9661 CST, 1:400) or CD44 (3570 CST, 1:400).
After further washes in blocking buffer, samples were incubated overnight at 4 C with a
solution of secondary antibody in blocking buffer (a21042/a21050/a11010/a11029/a11034
Invitrogen, 1:400). For HA staining, biotinylated hyaluronic acid binding protein (bHABP,
AMS.HKD-BC41 AMSBio, 1:100) was added with the primary antibody, and TRITC-streptavidin
(Stratech) with the secondary antibody. Samples were incubated in a 300 nM DAPI solution
(D3571 Invitrogen) for 1 hour at room temperature prior to imaging. For heparan sulphate
staining (10e4, 370255-1 AMSBio, 1:100), 10% goat serum (Sigma) in PBS was substituted
as blocking buffer, with Hoechst substituted in place of DAPI counterstain. Where Phalloidin
was used for F-Actin staining (F432/R415, Thermofisher, 1:1000), this was added either alone
or with the secondary antibody, as a solution in blocking buffer as described above.
6.11. Embedding and Sectioning
Peptide gels were embedded in a 2-4% solution of agar (SLS) in distilled water, and set
for several hours at 4 C prior to further processing. Agar blocks were sectioned using a
Leica Vibratome at a thickness of 500 µm. Agar slices were stored in PBS, and were stained
using the same immunofluorescence techniques described above. Alternatively, the agar
blocks were transferred to a tissue processor and set in a paraffin block. 10 µm slices were
sectioned onto SuperFrost slides (Thermo Scientific, UK) using a microtome. After drying at
37 C, slides were dewaxed in xylene and rehydrated in an ethanol series to allow staining
with Haematoxylin and Eosin (3 minutes each). Slides were washed in running water at each
stage, and incubated for 20 seconds in acid alcohol and 1 minute in Scott’s tap water between
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stains. Slides were dehydrated, cleared in xylene, and coverslipped using DPX mounting
medium (Thermo Scientific, UK).
6.12. Quantitative Reverse Transcription PCR (qRT-PCR)
Total RNA was extracted and purified from cells within peptide gels using the Nucleospin
RNA kit (Machery Nagel) according to the manufacturer’s instructions. 700 µg of RNA was
reverse-transcribed to cDNA using SuperScriptTM III Reverse Transcriptase, following the
manufacturer’s instructions. The GoTaq qPCR Master Mix (Promega) was used to run the
PCR reaction on a LightCycler® 480 (Roche). Human RPLPO and HSP90AB1 were used as
reference genes for normalisation and hiPSCs cultured in 2D were used to calculate relative
expression using the   Ct method. Primers used are listed in supplementary table 1.
6.13. Statistics
Prism v.7.0d and SPSS v.24 (IBM) were used for statistical analysis. One-way or two-way
ANOVA with Tukey HSD post-hoc test were used as appropriate where measurements were
normally distributed, verified by the Shapiro-Wilk test. In the one case where the data were
not normally distributed (the acini diameter measurements in figure 10), a non-parametric
Kruskal-Wallis test was used with Bonferroni correction for multiple comparisons. Statistical
significance for all tests was declared at p<0.05.
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Supplementary Data: Peptide Gels of Fully-Deﬁned Composition and Mechanics for 
Probing Cell-Cell and Cell-Matrix Interactions In Vitro
Supplementary Figure 1: Control rheological measurements for validation of the micro and 
bulk rheology experimental set-ups, and comparison to literature-published data: (a) 
complex viscosity (η*) versus frequency of water measured using microrheology combined 
with optical tweezers and an optically trapped 2 µm diameter polystyrene bead in water. 
Water viscosity at room temperature is circa η* = 10-3 Pa.s [1]; (b) x-y raw data of bead 
displacement from equilibrium position, presented as a scatter plot and (c, d) as a function of 
time; (e) complex viscosity of 100% MatrigelTM measured using bulk rheology and 
microrheology, with (f) the storage modulus calculated from bulk rheology showing a value 
of G’ ~ 200 Pa as previously published [2].
Supplementary Figure 2: Macroscopic contraction and viscous mechanical response of 
MatrigelTM, collagen gels and peptide gels. Raw images of ﻿macroscopic contraction are 
shown at (a) day 1 and (b, c) day 7, in 100% MatrigelTM, 1.5 mg/mL rat tail collagen I gel, 
unmodified 6 mg/mL peptide gel, and 6 mg/mL peptide gels modified with collagen I as 
indicated. Images are 3 mm across and correspond to the annotated versions in figure 5, 
main text. Viscous mechanical response, quantified by measurement of (d) loss modulus G’’ 
and (e) tan δ is also shown, corresponding to the G’ (storage modulus) data in figure 5, main 
text. * indicates statistical significance (p < 0.05, two-way ANOVA with Tukey post-hoc).
Supplementary Figure 3: Schematic of the different processing routes that may be followed 
to allow peptide gel physical sectioning. Paraformaldehyde-fixed peptide gels are pre-
embedded in agar (to enhance structural stability) and may then be processed either using 
conventional methods for paraffin embedding and microtomy, or directly thick-sectioned 
using a vibratome.
Supplementary Figure 4: Negative control images (IgG and streptavidin) for the 
immunostaining images in figure 6, main text: (a) collagen I immunostaining in unmodified 6 
mg/mL peptide gels and with collagen I modification; (b) co-stain for exogenous collagen I 
and endogenous HA (biotinylated hyaluronic acid binding protein, bHABP, detected using 
TRITC-streptavidin) in 6 mg/mL peptide gel modified with collagen I. Scale bar 50 µm.
Supplementary Figure 5: Bar charts showing rheological characterisation (a-c) and 
quantification of cell viability (d-f) on matched samples from a representative live/dead assay 
as presented in figure 7, main text, showing the cell-type dependent nature of the link 
between gel stiffness (storage modulus, G’) and % live cells within the gel.
Supplementary Figure 6: Viscoelastic parameters G’’ (loss modulus) and tan δ of modified 
peptide gels quantified by bulk oscillatory rheology. Panels (a, b) correspond to G’ (storage 
modulus) measurements in figure 9, main text, panels (c, d) correspond to G’ measurements 
in figure 10, main text. * indicates statistical significance (p < 0.05, one-way ANOVA with 
Tukey post-hoc).
Supplementary Figure 7: Phalloidin staining revealing morphology of MCF10A acini grown 
in monoculture to day 14, within 10 mg/ml peptide gels with additions as indicated. Left to 
right: 20% Matrigel (as figure 9, main text); 100 µg/ml collagen I (as figure 10, main text); 
100 µg/mL hyaluronan (HA); 100 ug/ml collagen I + 50 µg/ml HA. Scale bar 50 µm.
Supplementary Table 1: List of primer sequences used for RT-qPCR analysis as shown in 
figure 4, main text. All primers are listed as 5’-3’ sequences.
Gene Forward primer Reverse primer
RPLP0 GGCGACCTGGAAGTCCAA TTGTCTGCTCCCACAATGAAAC
HSP90AB1 CCTCACTAATGACTGGGAAGAC GGAGCCCGACGAGGAATAAA
NANOG GCAGAAGGCCTCAGCACCTA AGGTTCCCAGTCGGGTTCA
OCT4 GCTCGAGAAGGATGTGGTCC CGTTGTGCATAGTCGCTGCT
TUBB3 AACGAGGCCTCTTCTCACAA GGCCTGAAGAGATGTCCAAA
GATA6 GCAAAAATACTTCCCCCACA TCTCCCGCACCAGTCATC
HAND1 AACTCAAGAAGGCGGATGG CGGTGCGTCCTTTAATCCT
Supplementary Movie 1: Typical 3D distribution of MCF10A (CK18+, green) and HMF 
(CK18-) grown in direct coculture for 7 days in the peptide gel (6 mg/mL condition, figure 8, 
main text). DAPI (blue) was used as counterstain. Images were taken with an Opera 
PhenixTM System (Perkin-Elmer, UK) using a x20 water immersion lens.
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